AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 44 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,225,000 | +227.4% | 2,353,400 | -13.0% | 0.01% | +250.0% |
| Q1 2017 | $1,596,000 | +7.7% | 2,704,400 | -1.4% | 0.00% | 0.0% |
| Q4 2016 | $1,482,000 | -35.8% | 2,743,900 | +5.7% | 0.00% | -50.0% |
| Q3 2016 | $2,310,000 | -0.1% | 2,595,400 | +7.9% | 0.00% | 0.0% |
| Q2 2016 | $2,312,000 | +20.0% | 2,405,400 | +14.8% | 0.00% | 0.0% |
| Q1 2016 | $1,927,000 | -22.6% | 2,094,900 | +6.0% | 0.00% | -20.0% |
| Q4 2015 | $2,490,000 | -1.6% | 1,975,900 | -5.5% | 0.01% | -16.7% |
| Q3 2015 | $2,531,000 | -31.4% | 2,091,800 | -1.4% | 0.01% | -25.0% |
| Q2 2015 | $3,690,000 | +99.5% | 2,120,800 | +66.2% | 0.01% | +100.0% |
| Q1 2015 | $1,850,000 | +225.7% | 1,276,000 | +88.8% | 0.00% | +300.0% |
| Q4 2014 | $568,000 | -13.5% | 675,800 | +14.2% | 0.00% | -50.0% |
| Q3 2014 | $657,000 | -73.3% | 591,700 | -56.0% | 0.00% | -66.7% |
| Q2 2014 | $2,459,000 | +28.9% | 1,343,488 | +5.3% | 0.01% | +20.0% |
| Q1 2014 | $1,907,000 | -19.8% | 1,275,453 | -1.8% | 0.01% | -16.7% |
| Q4 2013 | $2,377,000 | -11.8% | 1,299,070 | -0.7% | 0.01% | -14.3% |
| Q3 2013 | $2,696,000 | -11.4% | 1,308,753 | +7.5% | 0.01% | -12.5% |
| Q2 2013 | $3,043,000 | – | 1,217,363 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|